Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 29, 2026.

Diversity among Multidrug-Resistant Enterococci

Barbara E. Murray

Emerging Infectious Diseases · 1998 · Review

doi:10.3201/eid0401.980106

Abstract

Enterococci are associated with both community- and hospital-acquired infections. Even though they do not cause severe systemic inflammatory responses, such as septic shock, enterococci present a therapeutic challenge because of their resistance to a vast array of antimicrobial drugs, including cell-wall active agents, all commercially available aminoglycosides, penicillin and ampicillin, and vancomycin. The combination of the latter two occurs disproportionately in strains resistant to many other antimicrobial drugs. The propensity of enterococci to acquire resistance may relate to their ability to participate in various forms of conjugation, which can result in the spread of genes as part of conjugative transposons, pheromone-responsive plasmids, or broad host-range plasmids. Enterococcal hardiness likely adds to resistance by facilitating survival in the environment (and thus enhancing potential spread from person to person) of a multidrug-resistant clone. The combination of these attributes within the genus Enterococcus suggests that these bacteria and their resistance to antimicrobial drugs will continue to pose a challenge.

References 71

  1. 1.

    Aarestrup F. M., Ahrens P., Madsen M., Pallesen L. V., Poulsen R. L., Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996;40(8):1938-1940.

    Not in our library10.1128/aac.40.8.1938

  2. 2.

    Arthur M., Molinas C., Bugg T. D., Wright G. D., Walsh C. T., Courvalin P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1992;36(4):867-869.

    Not in our library10.1128/aac.36.4.867

  3. 3.

    Bates J., Jordens Z., Selkon J. B. Evidence for an animal origin of vancomycin-resistant enterococci. Lancet. 1993;342(8869):490-491.

    Not in our library10.1016/0140-6736(93)91613-q

  4. 4.

    Biavasco F., Miele A., Vignaroli C., Manso E., Lupidi R., Varaldo P. E. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist. 1996;2(2):231-237.

    Not in our library10.1089/mdr.1996.2.231

  5. 5.

    Billot-Klein D., Gutmann L., Sablé S., Guittet E., van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol. 1994;176(8):2398-2405.

    Not in our library10.1128/jb.176.8.2398-2405.1994

  6. 6.

    Bingen E. H., Denamur E., Lambert-Zechovsky N. Y., Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol. 1991;29(9):1888-1892.

    Not in our library10.1128/jcm.29.9.1888-1892.1991

  7. 7.

    Boyce J. M., Opal S. M., Chow J. W., Zervos M. J., Potter-Bynoe G., Sherman C. B., Romulo R. L., Fortna S., Medeiros A. A. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994;32(5):1148-1153.

    Not in our library10.1128/jcm.32.5.1148-1153.1994

  8. 8.

    Boyle J. F., Soumakis S. A., Rendo A., Herrington J. A., Gianarkis D. G., Thurberg B. E., Painter B. G. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31(5):1280-1285.

    Not in our library10.1128/jcm.31.5.1280-1285.1993

  9. 9.

    Carlier C., Courvalin P. Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother. 1990;34(8):1565-1569.

    Not in our library10.1128/aac.34.8.1565

  10. 10.

    Chenoweth C. E., Robinson K. A., Schaberg D. R. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother. 1990;34(9):1800-1802.

    Not in our library10.1128/aac.34.9.1800

  11. 11.

    Chow J. W., Kuritza A., Shlaes D. M., Green M., Sahm D. F., Zervos M. J. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol. 1993;31(6):1609-1611.

    Not in our library10.1128/jcm.31.6.1609-1611.1993

  12. 12.

    Chow J. W., Zervos M. J., Lerner S. A., Thal L. A., Donabedian S. M., Jaworski D. D., Tsai S., Shaw K. J., Clewell D. B. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother. 1997;41(3):511-514.

    Not in our library10.1128/aac.41.3.511

  13. 13.

    Clark N. C., Cooksey R. C., Hill B. C., Swenson J. M., Tenover F. C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993;37(11):2311-2317.

    Not in our library10.1128/aac.37.11.2311

  14. 14.

    Clewell D. B., Gawron-Burke C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol. 1986;40:635-659.

    Not in our library10.1146/annurev.mi.40.100186.003223

  15. 15.

    Clewell D. B. Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev. 1981;45(3):409-436.

    Not in our library10.1128/mr.45.3.409-436.1981

  16. 16.

    Clewell D. B., Weaver K. E. Sex pheromones and plasmid transfer in Enterococcus faecalis. Plasmid. 1989;21(3):175-184.

    Not in our library10.1016/0147-619x(89)90041-3

  17. 17.

    Coque T. M., Tomayko J. F., Ricke S. C., Okhyusen P. C., Murray B. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996;40(11):2605-2609.

    Not in our library10.1128/aac.40.11.2605

  18. 18.

    Coudron P. E., Markowitz S. M., Wong E. S. Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother. 1992;36(5):1125-1126.

    Not in our library10.1128/aac.36.5.1125

  19. 19.

    Derlot E., Courvalin P. Mechanisms and implications of glycopeptide resistance in enterococci. Am J Med. 1991;91(3B):82S-85S.

    Not in our library10.1016/0002-9343(91)90348-2

  20. 20.

    Dutka-Malen S., Molinas C., Arthur M., Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene. 1992;112(1):53-58.

    Not in our library10.1016/0378-1119(92)90302-6

  21. 21.

    Eliopoulos G. M., Wennersten C., Zighelboim-Daum S., Reiszner E., Goldmann D., Moellering R. C. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother. 1988;32(10):1528-1532.

    Not in our library10.1128/aac.32.10.1528

  22. 22.

    Ferretti J. J., Gilmore K. S., Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol. 1986;167(2):631-638.

    Not in our library10.1128/jb.167.2.631-638.1986

  23. 23.

    Fontana R., Ligozzi M., Pittaluga F., Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist. 1996;2(2):209-213.

    Not in our library10.1089/mdr.1996.2.209

  24. 24.

    Grayson M. L., Eliopoulos G. M., Wennersten C. B., Ruoff K. L., De Girolami P. C., Ferraro M. J., Moellering R. C. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother. 1991;35(11):2180-2184.

    Not in our library10.1128/aac.35.11.2180

  25. 25.

    Grayson M. L., Thauvin-Eliopoulos C., Eliopoulos G. M., Yao J. D., DeAngelis D. V., Walton L., Woolley J. L., Moellering R. C. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1990;34(9):1792-1794.

    Not in our library10.1128/aac.34.9.1792

  26. 26.

    Handwerger S., Perlman D. C., Altarac D., McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis. 1992;14(3):655-661.

    Not in our library10.1093/clinids/14.3.655

  27. 27.

    Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16(6):750-755.

    Not in our library10.1093/clind/16.6.750

  28. 28.

    Handwerger S., Skoble J., Discotto L. F., Pucci M. J. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob Agents Chemother. 1995;39(2):362-368.

    Not in our library10.1128/aac.39.2.362

  29. 29.

    Handwerger S., Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1995;39(11):2446-2453.

    Not in our library10.1128/aac.39.11.2446

  30. 30.

    Hodel-Christian S. L., Murray B. E. Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother. 1991;35(6):1147-1152.

    Not in our library10.1128/aac.35.6.1147

  31. 31.

    Hodges T. L., Zighelboim-Daum S., Eliopoulos G. M., Wennersten C., Moellering R. C. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother. 1992;36(1):121-125.

    Not in our library10.1128/aac.36.1.121

  32. 32.

    Jordens J. Z., Bates J., Griffiths D. T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1994;34(4):515-528.

    Not in our library10.1093/jac/34.4.515

  33. 33.

    Kjerulf A., Pallesen L., Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS. 1996;104(6):475-479.

    Not in our library10.1111/j.1699-0463.1996.tb00744.x

  34. 34.

    Klare I., Heier H., Claus H., Böhme G., Marin S., Seltmann G., Hakenbeck R., Antanassova V., Witte W. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist. 1995;1(3):265-272.

    Not in our library10.1089/mdr.1995.1.265

  35. 35.

    Klare I., Heier H., Claus H., Reissbrodt R., Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995;125(2-3):165-171.

    Not in our library10.1111/j.1574-6968.1995.tb07353.x

  36. 36.

    Klare I., Heier H., Claus H., Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett. 1993;106(1):23-29.

    Not in our library10.1111/j.1574-6968.1993.tb05930.x

  37. 37.

    Livornese L. L., Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M. E. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117(2):112-116.

    Not in our library10.7326/0003-4819-117-2-112

  38. 38.

    Miranda A. G., Singh K. V., Murray B. E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol. 1991;29(12):2752-2757.

    Not in our library10.1128/jcm.29.12.2752-2757.1991

  39. 39.

    Moellering R. C. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis. 1992;14(6):1173-1176.

    Not in our library10.1093/clinids/14.6.1173

  40. 40.

    Moellering R. C., Wennersten C., Medrek T., Weinberg A. N. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agents Chemother (Bethesda). 1970;10:335-340.

    Not in our library

  41. 41.

    Moreno F., Grota P., Crisp C., Magnon K., Melcher G. P., Jorgensen J. H., Patterson J. E. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995;21(5):1234-1237.

    Not in our library10.1093/clinids/21.5.1234

  42. 42.

    Morris J. G., Shay D. K., Hebden J. N., McCarter R. J., Perdue B. E., Jarvis W., Johnson J. A., Dowling T. C., Polish L. B., Schwalbe R. S. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med. 1995;123(4):250-259.

    Not in our library10.7326/0003-4819-123-4-199508150-00002

  43. 43.

    Murray B. E. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother. 1992;36(11):2355-2359.

    Not in our library10.1128/aac.36.11.2355

  44. 44.

    Murray B. E., Singh K. V., Heath J. D., Sharma B. R., Weinstock G. M. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990;28(9):2059-2063.

    Not in our library10.1128/jcm.28.9.2059-2063.1990

  45. 45.

    Murray B. E., Singh K. V., Markowitz S. M., Lopardo H. A., Patterson J. E., Zervos M. J., Rubeglio E., Eliopoulos G. M., Rice L. B., Goldstein F. W. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis. 1991;163(4):780-785.

    Not in our library10.1093/infdis/163.4.780

  46. 46.

    Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990;3(1):46-65.

    Not in our library10.1128/cmr.3.1.46

  47. 47.

    Najjar A., Murray B. E. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob Agents Chemother. 1987;31(5):808-810.

    Not in our library10.1128/aac.31.5.808

  48. 48.

    Navarro F., Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother. 1994;38(8):1788-1793.

    Not in our library10.1128/aac.38.8.1788

  49. 49.

    Patterson J. E., Singh K. V., Murray B. E. Epidemiology of an endemic strain of beta-lactamase-producing Enterococcus faecalis. J Clin Microbiol. 1991;29(11):2513-2516.

    Not in our library10.1128/jcm.29.11.2513-2516.1991

  50. 50.

    Perichon B., Reynolds P., Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997;41(9):2016-2018.

    Not in our library10.1128/aac.41.9.2016

  51. 51.

    Perlada D. E., Smulian A. G., Cushion M. T. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol. 1997;35(9):2342-2347.

    Not in our library10.1128/jcm.35.9.2342-2347.1997

  52. 52.

    Phillips I., King A., Gransden W. R., Eykyn S. J. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. J Antimicrob Chemother. 1990;25(Suppl 100):59-80.

    Not in our library10.1093/jac/25.suppl_c.59

  53. 53.

    Plessis P., Lamy T., Donnio P. Y., Autuly F., Grulois I., Le Prisé P. Y., Avril J. L. Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur J Clin Microbiol Infect Dis. 1995;14(11):959-963.

    Not in our library10.1007/bf01691377

  54. 54.

    Power E. G., Abdulla Y. H., Talsania H. G., Spice W., Aathithan S., French G. L. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother. 1995;36(4):595-606.

    Not in our library10.1093/jac/36.4.595

  55. 55.

    Rhinehart E., Smith N. E., Wennersten C., Gorss E., Freeman J., Eliopoulos G. M., Moellering R. C., Goldmann D. A. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990;323(26):1814-1818.

    Not in our library10.1056/nejm199012273232606

  56. 56.

    Rice L. B., Carias L. L., Marshall S. H., Bonafede M. E. Sequences found on staphylococcal beta-lactamase plasmids integrated into the chromosome of Enterococcus faecalis CH116. Plasmid. 1996;35(2):81-90.

    Not in our library10.1006/plas.1996.0010

  57. 57.

    Roberts M. C. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother. 1990;34(3):476-478.

    Not in our library10.1128/aac.34.3.476

  58. 58.

    Roberts M. C., Hillier S. L. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother. 1990;34(2):261-264.

    Not in our library10.1128/aac.34.2.261

  59. 59.

    Sader H. S., Pfaller M. A., Tenover F. C., Hollis R. J., Jones R. N. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol. 1994;32(11):2840-2842.

    Not in our library10.1128/jcm.32.11.2840-2842.1994

  60. 60.

    Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91(3B):72S-75S.

    Not in our library10.1016/0002-9343(91)90346-y

  61. 61.

    Schouten M. A., Voss A., Hoogkamp-Korstanje J. A. VRE and meat. Lancet. 1997;349(9060):1258-1258.

    Not in our library10.1016/s0140-6736(05)62461-0

  62. 62.

    Seetulsingh P. S., Tomayko J. F., Coudron P. E., Markowitz S. M., Skinner C., Singh K. V., Murray B. E. Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol. 1996;34(8):1892-1896.

    Not in our library10.1128/jcm.34.8.1892-1896.1996

  63. 63.

    Thal L. A., Chow J. W., Clewell D. B., Zervos M. J. Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1994;38(5):1152-1156.

    Not in our library10.1128/aac.38.5.1152

  64. 64.

    Tomayko J. F., Murray B. E. Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis. J Clin Microbiol. 1995;33(11):2903-2907.

    Not in our library10.1128/jcm.33.11.2903-2907.1995

  65. 65.

    Van der Auwera P., Pensart N., Korten V., Murray B. E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996;173(5):1129-1136.

    Not in our library10.1093/infdis/173.5.1129

  66. 66.

    Watanakunakorn C. The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988. J Antimicrob Chemother. 1989;24(1):63-68.

    Not in our library10.1093/jac/24.1.63

  67. 67.

    Wells V. D., Wong E. S., Murray B. E., Coudron P. E., Williams D. S., Markowitz S. M. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med. 1992;116(4):285-292.

    Not in our library10.7326/0003-4819-116-4-285

  68. 68.

    Zervos M. J., Dembinski S., Mikesell T., Schaberg D. R. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 1986;153(6):1075-1083.

    Not in our library10.1093/infdis/153.6.1075

  69. 69.

    Zervos M. J., Mikesell T. S., Schaberg D. R. Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis. Antimicrob Agents Chemother. 1986;30(1):78-81.

    Not in our library10.1128/aac.30.1.78

  70. 70.

    Zervos M. J., Schaberg D. R. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother. 1985;28(3):446-448.

    Not in our library10.1128/aac.28.3.446

  71. 71.

    van den Bogaard A. E., Jensen L. B., Stobberingh E. E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997;337(21):1558-1559.

    Not in our library10.1056/nejm199711203372117

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.